1-6 of 6
James D. Griffin, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NOTCH1-Induced T-Cell Leukemia in Transgenic Zebrafish.

Jihua Chen, PhD, Cicely Jette, Ph.D., John P. Kanki, Ph.D., Jon Aster, M.D.,Ph.D., A. Thomas Look, M.D., James D. Griffin, M.D.
Journal: Blood
Blood (2006) 108 (11): 1825.
https://doi.org/10.1182/blood.V108.11.1825.1825
Published: 2006
Journal Articles

The Jak2 V617F Oncogene Associated with Polycythemia Vera Requires a Functional FERM Domain for Transformation and for Expression of the Myc and Pim Proto-Oncogenes.

Martin Sattler, PhD, Brian J. Crowley, Jeffrey R. Gonneville, Jeremy Ho, Heidi H. Hudon, Klaus Podar, M.D., Ph.D., Yohan Royer, Stefan N. Constantinescu, M.D., Ph.D., James D. Griffin, M.D.
Journal: Blood
Blood (2006) 108 (11): 3611.
https://doi.org/10.1182/blood.V108.11.3611.3611
Published: 2006
Journal Articles

The MAML1 Transcriptional Co-Activator Is Required for the Development of Marginal Zone B Cells.

Lizi Wu, PhD, Ivan Maillard, Ph.D., Makoto Nakamura, M.D., Warren S. Pear, M.D. Ph.D., James D. Griffin, M.D.
Journal: Blood
Blood (2006) 108 (11): 777.
https://doi.org/10.1182/blood.V108.11.777.777
Published: 2006
Journal Articles

PKC412 Effectively Inhibits Constitutively Activated FGFR3 Mutants in Murine Leukemia Models and t(4;14) Myeloma Cell Lines.

Jing Chen, Ph.D., Benjamin H. Lee, M.D., Ph.D., Ifor R. Williams, M.D., Ph.D., Jeffery L. Kutok, M.D., Ph.D., Nicole Duclos, Sarah Cohen, Jennifer Adelsperger, Rachel Okabe, Allison Coburn, Sandra Moore, Brian J.P. Huntly, M.D., Ph.D., Constantine S. Mitsiades, M.D., Kenneth C. Anderson, M.D., James D. Griffin, M.D., Doriano Fabbro, Ph.D., D. Gary Gilliland, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2448.
https://doi.org/10.1182/blood.V104.11.2448.2448
Published: 2004
Journal Articles

PKC412 Inhibits the ZNF198-FGFR1 Fusion Tyrosine Kinase and Is Efficacious in Treatment of t(8;13)(p11;q12) Associated Stem Cell Myeloproliferative Disease.

Jing Chen, Ph.D., Daniel J. DeAngelo, M.D., Jeffery L. Kutok, M.D., Ph.D., Ifor R. Williams, M.D., Ph.D., Benjamin H. Lee, M.D., Ph.D., Martha Wadleigh, M.D., Nicole Duclos, Sarah Cohen, Jennifer Adelsperger, Rachel Okabe, Allison Coburn, Ilene Galinsky, Brian J.P. Huntly, M.D., Ph.D., Pamela Cohen, Ph.D., Thomas Meyer, Ph.D., Doriano Fabbro, Ph.D., Lolita Banerji, Ph.D., James D. Griffin, M.D., Sheng Xiao, M.D., Jonathan A. Fletcher, M.D., Richard M. Stone, M.D., D. Gary Gilliland, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2549.
https://doi.org/10.1182/blood.V104.11.2549.2549
Published: 2004
Journal Articles

Pim Kinases Mediate Viability Signals Downstream of the Tyrosine Kinase Oncogenes BCR-ABL and FLT3-ITD.

Martin Sattler, Ph.D., Emily Babendreier, Stephanie C. Chu, Jessica L. Gramlich, Klaus Podar, M.D., Ph.D., James D. Griffin, M.D.
Journal: Blood
Blood (2004) 104 (11): 557.
https://doi.org/10.1182/blood.V104.11.557.557
Published: 2004